Cell Signaling Technology

Product Pathways - Tyrosine Kinase / Adaptors

Phospho-Bcr (Tyr177) Antibody #3901

Abl   BCR-Abl  

No. Size Price
3901S 100 µl ( 10 western blots ) ¥4,050.00 现货查询 购买询价 防伪查询
3901 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype
W 1:1000 Human,Mouse, Endogenous 160 (Bcr); 210 (Bcr-Abl) Rabbit
IHC-P 1:50
F 1:50

Species cross-reactivity is determined by western blot.

Applications Key: W=Western Blotting, IHC-P=Immunohistochemistry (Paraffin), F=Flow Cytometry,

Specificity / Sensitivity

Phospho-Bcr (Tyr177) Antibody detects endogenous levels of Bcr and Bcr-Abl only when phosphorylated at tyrosine 177.

Phospho-Bcr (Tyr177)兔多抗能检测酪氨酸(177位点)磷酸化的内源性Bcr、Bcr-Abl蛋白水平。

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Tyr177 of human Bcr. Antibodies are purified by protein A and peptide affinity chromatography.


Western Blotting

Western Blotting

Western blot analysis of extracts from K562 cells, untreated or calf intestinal phosphatase (CIP)-treated, using Phospho-Bcr (Tyr177) Antibody (upper) or Bcr Antibody #3902 (lower).western blot方法检测细胞提取物:未经处理和牛小肠磷酸酶CIP)处理的 K562细胞,使用的抗体是Phospho-Bcr (Tyr177) Antibody (上图) 和 Bcr Antibody #3902 (下图)。

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded bone marrow from a patient with chronic myelogenous leukemia, showing membrane and cytoplasmic localization, using Phospho-Bcr (Tyr177) Antibody.免疫组织化学方法检测石蜡包埋的白血病病人骨髓组织,显示胞膜和细胞质位置。使用的抗体是Phospho-Bcr (Tyr177) Antibody。

Western Blotting

Western Blotting

Western blot analysis of extracts from PAE/CKR cells (expressing chimeric receptors of the extracellular domain of CSF-1R, and transmembrane and cytoplasmic domains of KDR) stimulated with CSF-1 (40 ng/ml for 5 minutes) or NIH/3T3 cells stimulated with PDGF (40 ng/ml for 2 minutes) using Phospho-Bcr (Tyr177) Antibody (upper) or Bcr Antibody #3902 (lower).western blot方法检测细胞提取物:CSF-1 (40 ng/ml,5 min)刺激的PAE/CKR细胞(表达CSF-1R胞外区域的嵌合受体)和NIH/3T3细胞刺激的PDGF (40 ng/ml,2 min)。使用的抗体是Phospho-Bcr (Tyr177) Antibody (上图) 和 Bcr Antibody #3902 (下图)。

Flow Cytometry

Flow Cytometry

Flow cytometric analysis of K562 cells, untreated (green) or Gleevec® (STI571)- treated (blue), using Phospho-Bcr (Tyr177) Antibody compared to a nonspecific negative control antibody (red).Flow Cytometry方法检测细胞提取物:未经处理(绿色)的和Gleevec® (STI571)处理的(蓝色)K562细胞,使用的抗体是Phospho-Bcr (Tyr177),红色表示非特异性阴性对照抗体。


The Bcr gene was orginally identified by its presence in the chimeric Bcr-Abl oncogene (1). The amino-terminal region of Bcr contains an oligomerization domain, a serine/threonine kinase domain and a region that binds SH2 domains. The middle of the protein has a PH domain and a region of sequence similarity to the guanine nucleotide exchange factors for the Rho family of GTP binding proteins. The carboxy-terminal region may be involved in a GTPase activating function for the small GTP-binding protein Rac (2,3). The function of wild type Bcr in cells remains unclear. PDGF receptor may use Bcr as a downstream signaling mediator (4). The Bcr-Abl fusion results in production of a constitutively active tyrosine kinase, which causes chronic myelogenous leukemia (CML) (5). Tyr177 of Bcr is phosphorylated in the Bcr-Abl fusion protein, which plays an important role in transforming the activity of Bcr-Abl (6). Phosphorylated Tyr177 of Bcr provides a docking site for Gab2 and GRB2 (7,8).

Bcr蛋白基因最早在嵌合的 Bcr-Abl致癌基因中发现(1),Bcr蛋白胺端区域包含一个寡聚化反应区域——丝氨酸/苏氨酸激酶区域,以及能结合SH2的区域。该蛋白质中心区域有一个PH结构域和一个与鸟苷酸交换因子序列相近的区域,是Rho家族的GTP结合蛋白。C端区域可能涉及到一个对小GTP结合蛋白Rac 的GTP酶活化作用(2,3)。原株Bcr in细胞的作用机制尚不清楚。PDGF受体可能将Bcr蛋白当作下游信号调节子来使用(4)。研究表明Bcr-Abl的融合导致结构性活化酪氨酸激酶的产生,该激酶会引起白血病(CML)(5). Bcr-Abl融合蛋白中Bcr蛋白酪氨酸(177位点)被磷酸化,该磷酸化作用对转变Bcr-Abl蛋白的活性十分重要(6)。磷酸化的酪氨酸(177位点)为Gab2 、GRB2提供了一个“停泊位点”(7,8)。

  1. Groffen, J. et al. (1984) Cell 36, 93-99.
  2. Maru, Y. et al. (1991) Cell 67, 459-468.
  3. Che, W. et al. (2001) Circulation 104, 1399-1406.
  4. Abe, J. I. et al. (2001) Ann. N.Y. Acad. Sci. 947, 341-343.
  5. Voncken, J. W. et al. (1995) Cell 80, 719-728.
  6. He, Y. et al. (2002) Blood 99, 2957-2968.
  7. Sattler, M. et al. (2002) Cancer Cell 1, 479-492.
  8. Warmuth, M. et al. (1995) J. Biol. Chem. 272, 33260-33270.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!


Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0


我要参与评论 :